Publications by authors named "T H C Munnecom"
Article Synopsis
- Crohn's disease is a chronic condition with variable symptoms and treatment effectiveness, requiring careful management to avoid overtreatment, particularly in mild cases.
- A clinical trial will compare the effects of episodic treatment with the drug adalimumab against standard care starting with corticosteroids in newly diagnosed or flaring Crohn's disease patients, assessing various health outcomes over 96 weeks.
- The study aims to establish the benefits and safety of adalimumab while minimizing corticosteroid use and associated side effects, with ethical approval already granted for the research.
Cognitive complaints in the early phase after stroke are not indicative of cognitive impairment.
J Neurol Neurosurg Psychiatry
February 2008
Objective: The present study was designed to evaluate the diagnostic contribution of subjective information, obtained by a standardised checklist, to the identification of patients with cognitive impairment in the early phase after stroke.
Methods: The data were collected retrospectively by file analysis of both medical and psychological records of patients with a first-ever stroke who were discharged home from the stroke unit. All these patients underwent neuropsychological examination by protocol.